Sp423
COVID-19 AND THE LIVER: WHAT'S OLD, WHAT'S NEW, AND WHAT IS TO COME
Date
May 7, 2023
Explore related products in the following collection:
Society: AASLD
Presenter
Columbia University Medical Center
Tracks
Related Products
NON-INVASIVE PREDICTION OF HIGH-RISK ESOPHAGEAL VARICES VIA ELECTROCARDIOGRAM-BASED DEEP LEARNING MODEL
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
ALBUMIN USE AND AKI ARE INDEPENDENTLY ASSOCIATED WITH RESPIRATORY DISTRESS DEVELOPMENT IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS
BACKGROUND: Hepatorenal syndrome (HRS) with rapidly deteriorating kidney function can be effectively reversed when treated with terlipressin, the US FDA-approved vasopressin analogue…
GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
HIGH COMPLIANCE OF AASLD CIRRHOSIS QUALITY MEASURES IS ASSOCIATED WITH IMPROVED OUTCOMES IN CIRRHOSIS WITH ACUTE VARICEAL BLEEDING: SINGAPORE NATIONWIDE AUDIT
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
